Lysosome

From Wikipedia, the free encyclopedia
Cell biology
The animal cell

Components of a typical animal cell:
  1. Nucleolus
  2. Nucleus
  3. Ribosome (little dots)
  4. Vesicle
  5. Rough endoplasmic reticulum
  6. Golgi apparatus (or "Golgi body")
  7. Cytoskeleton
  8. Smooth endoplasmic reticulum
  9. Mitochondrion
  10. Vacuole
  11. Cytosol (fluid that contains organelles)
  12. Lysosome
  13. Centrosome
  14. Cell membrane
Lysosomes (derived from the Greek words lysis, meaning "to separate", and soma, "body") are the cell's waste disposal system and can digest some compounds. They are used for the digestion of macromolecules from phagocytosis (ingestion of other dying cells or larger extracellular material, like foreign invading microbes), endocytosis (where receptor proteins are recycled from the cell surface), and autophagy (wherein old or unneeded organelles or proteins, or microbes that have invaded the cytoplasm are delivered to the lysosome).

Other functions include digesting bacteria (or other forms of waste) that invade a cell and helping repair damage to the plasma membrane by serving as a membrane patch, sealing the wound. In the past, lysosomes were thought to kill cells that are no longer wanted, such as those in the tails of tadpoles or in the web from the fingers of a 3- to 6-month-old fetus.

Discovery

Christian de Duve, then chairman of the Laboratory of Physiological Chemistry at the Catholic University of Louvain in Belgium, had been studying the mechanism of action of a pancreatic hormone insulin in liver cells. By 1949 he and his team had focused on the enzyme called glucose 6-phosphatase, which is the first crucial enzyme in sugar metabolism and the target of insulin. They already suspected that this enzyme played a key role in regulating blood sugar levels. However, even after a series of experiments, they failed to purify and isolate the enzyme from the cellular extracts. Therefore they tried a more arduous procedure of cell fractionation, by which cellular components are separated based on their sizes using centrifugation. They succeeded in detecting the enzyme activity from the microsomal fraction. This was the crucial step in the serendipitous discovery. To estimate the enzyme activity, they used that of standardised enzyme acid phosphatase, and found that the activity was quite low (10% of the expected value). One day, the enzyme activity of purified cell fractions which had been refrigerated for five days was measured. Surprisingly the enzyme activity was increased to normal of that of the fresh sample. The result was the same no matter how many times they repeated the estimation. This led to the conclusion that a membrane-like barrier limited the accessibility of the enzyme to its substrate, so that the enzymes were able to diffuse after a few days. They described the membrane-like barrier as a "saclike structure surrounded by a membrane and containing acid phosphatase."[1] It became obvious that an unrelated enzyme from the cell fraction came from a membranous fractions which were definitely cell organelles, and in 1955 De Duve named them "lysosomes" to reflect their digestive properties.[2] That same year, Alex B. Novikoff from the University of Vermont visited de Duve´s laboratory, and successfully obtained the first electron micrographs of the new organelle. Using a staining method for acid phosphatase, de Duve and Novikoff confirmed the location of the hydrolytic enzymes of lysosomes using light and electron microscopic studies.[3][4] de Duve won the Nobel Prize in Physiology or Medicine in 1974 for this discovery.

Function and structure

Lysosomes are cellular organelles that contain acid hydrolase enzymes that break down waste materials and cellular debris. They can be described as the stomach of the cell. They are found in animal cells, while their existence in yeasts and plants is disputed. Some biologists say the same roles are performed by lytic vacuoles,[5] while others suggest there is strong evidence that lysosomes are indeed found in some plant cells.[6] Lysosomes digest excess or worn-out organelles, food particles, and engulf viruses or bacteria. The membrane around a lysosome allows the digestive enzymes to work at the pH they require. Lysosomes fuse with autophagic vacuoles and dispense their enzymes into the autophagic vacuoles, digesting their contents. They are frequently nicknamed "suicide-bags" or "suicide-sacs" by cell biologists due to their autolysis. A group of genetic inherited disorders called lysosomal storage diseases (LSD) results from the dysfunction of lysosomes.

The size of a lysosome varies from 0.11.2 μm.[7] At pH 4.8, the interior of the lysosomes is acidic compared to the slightly basic cytosol (pH 7.2). The lysosome maintains this pH differential by pumping protons (H+ ions) from the cytosol across the membrane via proton pumps and chloride ion channels. The lysosomal membrane protects the cytosol, and therefore the rest of the cell, from the degradative enzymes within the lysosome. The cell is additionally protected from any lysosomal acid hydrolases that drain into the cytosol, as these enzymes are pH-sensitive and do not function well or at all in the alkaline environment of the cytosol.This ensures that cytosolic molecules and organelles are not lysed in case there is leakage of the hydrolytic enzymes from the lysosome.

Formation

Many components of animal cells are recycled by transferring them inside or embedded in sections of membrane. For instance, in endocytosis, a portion of the cell’s plasma membrane pinches off to form a vesicle that will eventually fuse with an organelle within the cell. Without active replenishment, the plasma membrane would continuously decrease in size. It is thought that lysosomes participate in this dynamic membrane exchange system and are formed by a gradual maturation process from endosomes.[8]

The production of lysosomal proteins suggests one method of lysosome sustainment. Lysosomal protein genes are transcribed in the nucleus. mRNA transcripts exit the nucleus into the cytosol, where they are translated by ribosomes. The nascent peptide chains are translocated into the rough endoplasmic reticulum, where they are modified. Upon exiting the endoplasmic reticulum and entering the Golgi apparatus via vesicular transport, a specific lysosomal tag, mannose 6-phosphate, is added to the peptides. The presence of these tags allow for binding to mannose 6-phosphate receptors in the Golgi apparatus, a phenomenon that is crucial for proper packaging into vesicles destined for the lysosomal system.[9]

Upon leaving the Golgi apparatus, the lysosomal enzyme-filled vesicle fuses with a late endosome, a relatively acidic organelle with an approximate pH of 5.5. This acidic environment causes dissociation of the lysosomal enzymes from the mannose 6-phosphate receptors. The enzymes are packed into vesicles for further transport to established lysosomes.[9] The late endosome itself can eventually grow into a mature lysosome, as evidenced by the transport of endosomal membrane components from the lysosomes back to the endosomes.[8]

Lysosomotropism

Weak bases with lipophilic properties accumulate in acidic intracellular compartments like lysosomes. While the plasma and lysosomal membranes are permeable for neutral and uncharged species of weak bases, the charged protonated species of weak bases do not permeate biomembranes and accumulate within lysosomes. The concentration within lysosomes may reach levels 100 to 1000 fold higher than extracellular concentrations. This phenomenon is called "lysosomotropism"[10] or "acid trapping". The amount of accumulation of lysosomotropic compounds may be estimated using a cell based mathematical model.[11]

A significant part of the clinically approved drugs are lipophilic weak bases with lysosomotropic properties. This explains a number of pharmacological properties of these drugs, such as high tissue-to-blood concentration gradients or long tissue elimination half-lifes; these properties have been found for drugs such as haloperidol,[12] levomepromazine, [13] and amantadine.[14] However, high tissue concentrations and long elimination half-lives are explained also by lipophilicity and absorption of drugs to fatty tissue structures. Important lysosomal enzymes, such as acid sphingomyelinase, may be inhibited by lysososomally accumulated drugs.[15][16] Such compounds are termed FIASMAs (functional inhibitor of acid sphingomyelinase)[17] and include for example fluoxetine, sertraline, or amitriptyline.

References

  1. Susana Castro-Obregon (2010). "The Discovery of Lysosomes and Autophagy". Nature Education 3 (9): 49. 
  2. De Duve, C (2005). "The lysosome turns fifty". Nature cell biology 7 (9): 847–9. doi:10.1038/ncb0905-847. PMID 16136179. 
  3. Novikoff, AB; Beaufay, H; De Duve, C (1956). "Electron microscopy of lysosomerich fractions from rat liver". The Journal of biophysical and biochemical cytology 2 (4 Suppl): 179–84. doi:10.1083/jcb.2.4.179. PMC 2229688. PMID 13357540. 
  4. Klionsky, DJ (2008). "Autophagy revisited: A conversation with Christian de Duve". Autophagy 4 (6): 740–3. PMID 18567941. 
  5. Šamaj, Jozef; Read, Nick D.; Volkmann, Dieter; Menzel, Diedrik; Baluska, František (2005). "The endocytic network in plants". Trends in Cell Biology 15 (8): 425–33. doi:10.1016/j.tcb.2005.06.006. PMID 16006126. 
  6. Sarah J. Swansona, Paul C. Bethkea, and Russell L. Jonesa (May 1998). "Barley Aleurone Cells Contain Two Types of Vacuoles: Characterization of Lytic Organelles by Use of Fluorescent Probes". The Plant Cell 10 (5): 685–689. 
  7. Kuehnel, W (2003). Color Atlas of Cytology, Histology, & Microscopic Anatomy (4th ed.). Thieme. p. 34. ISBN 1-58890-175-0. 
  8. 8.0 8.1 Alberts, Bruce et al. (2002). Molecular biology of the cell (4th ed.). New York: Garland Science. ISBN 0-8153-3218-1. 
  9. 9.0 9.1 Lodish, Harvey et al. (2000). Molecular cell biology (4th ed.). New York: Scientific American Books. ISBN 0-7167-3136-3. 
  10. De Duve, C; De Barsy, T; Poole, B; Trouet, A; Tulkens, P; Van Hoof, F (1974). "Commentary. Lysosomotropic agents". Biochemical pharmacology 23 (18): 2495–531. PMID 4606365. 
  11. Trapp, S; Rosania, GR; Horobin, RW; Kornhuber, J (2008). "Quantitative modeling of selective lysosomal targeting for drug design". European Biophysics Journal : EBJ 37 (8): 1317–28. doi:10.1007/s00249-008-0338-4. PMC 2711917. PMID 18504571. 
  12. Kornhuber, J; Schultz, A; Wiltfang, J; Meineke, I; Gleiter, CH; Zöchling, R; Boissl, KW; Leblhuber, F et al. (1999). "Persistence of haloperidol in human brain tissue". The American Journal of Psychiatry 156 (6): 885–90. PMID 10360127. 
  13. Kornhuber, J; Weigmann, H; Röhrich, J; Wiltfang, J; Bleich, S; Meineke, I; Zöchling, R; Härtter, S; Riederer, P; Hiemke, C (2006). "Region specific distribution of levomepromazine in the human brain". Journal of Neural Transmission (Vienna, Austria : 1996) 113 (3): 387–97. doi:10.1007/s00702-005-0331-3. PMID 15997416. 
  14. Kornhuber, J; Quack, G; Danysz, W; Jellinger, K; Danielczyk, W; Gsell, W; Riederer, P (1995). "Therapeutic brain concentration of the NMDA receptor antagonist amantadine". Neuropharmacology 34 (7): 713–21. PMID 8532138. 
  15. Kornhuber, J; Tripal, P; Reichel, M; Terfloth, L; Bleich, S; Wiltfang, J; Gulbins, E (2008). "Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model". Journal of Medicinal Chemistry 51 (2): 219–37. doi:10.1021/jm070524a. PMID 18027916. 
  16. Kornhuber, J; Muehlbacher, M; Trapp, S; Pechmann, S; Friedl, A; Reichel, M; Mühle, C; Terfloth, L; Groemer, TW; Spitzer, GM; Liedl, KR; Gulbins, E; Tripal, P (2011). "Identification of novel functional inhibitors of acid sphingomyelinase". In Riezman, Howard. PloS ONE 6 (8): e23852. doi:10.1371/journal.pone.0023852. PMC 3166082. PMID 21909365. 
  17. Kornhuber, J; Tripal, P; Reichel, M; Mühle, C; Rhein, C; Muehlbacher, M; Groemer, TW; Gulbins, E (2010). "Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A novel pharmacological group of drugs with broad clinical applications". Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 26 (1): 9–20. doi:10.1159/000315101. PMID 20502000. 

External links

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.